Fifty 410 review

Take a lower tirzepatide dose here and you do pay less — barely. Fifty 410 publishes total milligrams against its rungs, and that alone makes the ladder checkable. But it is compressed: the higher of its two quantified rungs carries half again as much drug for about a tenth more money, so a patient holding low is paying most of a full-dose price for a fraction of the drug. And the cheapest rung is the one rung with no milligram total published at all — it says "Personalized starting dose", which means the low-dose buyer is the one who cannot check what they are getting. Credit where it is due: nothing is charged until a provider approves you, and the pricing page says so. Two more cautions. Every tirzepatide monthly figure is a three-month prepay divided by three, shipped in one go. And semaglutide has no ladder here at all.

Vs median

$30/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Quotes off the lowest dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Fifty 410 does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Fifty 410 sells compounded semaglutide and compounded tirzepatide as programs rather than subscriptions: the whole course ships at once after a provider approves it, and nothing is charged beforehand — "No credit card is required up front. Once approved by a licensed provider, you will be sent a payment link." Tirzepatide is priced in three-month programs with total milligrams published against two of the three rungs; semaglutide has a single one-month rung and no ladder at all. It publishes a public dosage calculator and says it serves "patients in most U.S. States" without enumerating them. No compounding pharmacy is named beyond "independent FDA-registered 503A and 503B compounding pharmacies".

The tirzepatide rungs are compressed. 216 mg costs $549 against $499 for 144 mg, so half again as much drug costs about a tenth more money — holding at a low dose saves you almost nothing against the top rung

• The cheapest rung, the $399 Starter Program, is the only one with no milligram total published. It says "Personalized starting dose", so the lowest-dose buyer is the one who cannot check what they are getting
• Every tirzepatide "/month" figure is arithmetic on a three-month prepay, not a monthly charge — "$133 /month" sits directly above "$399 total"
• Semaglutide has no ladder at all — one rung at $199 for a one-month supply, so there is nothing to hold low against
• The LegitScript claim appears only as a text link reading "LegitScript Approved", with no served seal image and no identifier
• No compounding pharmacy is named, and the states served are not enumerated — only "most U.S. States"
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Fifty 410 is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan